Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

J.D. Wetherspoon PLC Remuneration Information 2019

Oct 4, 2019

5214_dirs_2019-10-04_6b1dac39-97cb-43f9-9a3e-88880fcaa357.html

Remuneration Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8063O

Wetherspoon (JD) PLC

04 October 2019

JD Wetherspoon plc

("the Company")

Share Incentive Plan - Award

The Company was informed on the 03rd October 2019 that the following shares were awarded under the approved and unapproved Share Incentive Plan to the directors and Persons Discharging Managerial Responsibility (PDMRs) on 01st October 2019 at a price of 1543.00 pence per share:

Approved SIP Unapproved SIP
Directors
John Hutson 233 5,822
Su Cacioppo 233 3,166
Ben Whitley 233 1,589
PDMR -
Martin Geoghegan 233 2,163
David Capstick 233 2,308
Miles Slade 233 1,002
Nigel Connor 211 634
James Ullman 207 830

Following the above transactions, the directors and PDMR's now hold the following:

Total Approved SIPS held in Trust (less than 3 years) Total Unapproved SIPS held in Trust (less than 3 years) Shareholding including SIPS held in Trust (over 3 years)
Directors
John Hutson 1,175 50,551 118,423
Su Cacioppo 1,175 27,861 25,388
Ben Whitley 1,175 12,295 5,700
PDMR
Martin Geoghegan 1,175 16,564 32,166
David Capstick 1,175 20,668 45,189
Miles Slade 1,174 9,551 586
Nigel Connor 1,149 6,201 1,350
James Ullman 1,142 6,399 27,664

4th October 2019

Enquiries

JD Wetherspoon plc

Tel.: 01923 477777

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHGIBDGIDGBGCS